Concepedia

Publication | Open Access

Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age

128

Citations

26

References

2022

Year

Abstract

During a period when the omicron variant was predominant, BNT162b2 vaccination reduced the risks of SARS-CoV-2 infection and Covid-19-related hospitalization among children 5 to 11 years of age.

References

YearCitations

Page 1